ClinConnect ClinConnect Logo
Search / Trial NCT04617639

The Norwegian Trial of Physical Exercise After Myocardial Infarction

Launched by NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY · Oct 30, 2020

Trial Information

Current as of July 23, 2025

Enrolling by invitation

Keywords

Exercise Therapy Secondary Prevention

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Hospitalized in a Norwegian hospital with an acute myocardial infarction (Type I) during 2013-2022. Patients are included minimum 3 months after hospitalization when they are in a stable clinical condition.
  • 2. Norwegian national identification number
  • 3. Able to communicate in Norwegian or other Scandinavian language
  • 4. Being able to be physically active according to study protocol, as determined by study personnel.
  • 5. Signed informed consent.
  • Exclusion criteria:
  • 1. Persons who already participate in physical activity at a similar or higher level than what is prescribed for the intervention group, as determined by study personnel.
  • 2. Participating or plans to participate in endurance sport competitions.
  • 3. Expected to emigrate during the study
  • 4. Cognitive impairment/dementia.
  • 5. Alcohol or drug abuse, or serious psychiatric disease.
  • 6. Known cardiac disease that may represent a contraindication for moderate or high-intensity physical activity, such as symptomatic valvular heart disease, hypertrophic cardiomyopathy, uncontrolled hypertension, in-compensated heart failure, serious arrythmia not under control after treatment, pulmonary hypertension, significant angina after revascularization and optimal drug treatment.
  • 7. Renal insufficiency requiring dialysis.
  • 8. Any end-stage somatic disease with short life expectancy or that is expected to interfere with the participants' ability to comply with the study protocol, such as advanced cancer, chronic lung disease with exacerbations, or other disease, as determined by study personnel.
  • 9. Inability to comply with the study protocol due to any physical disability, somatic disease or mental problem, as determined by study personnel.
  • 10. Residing in nursing home or other institution.
  • 11. Participation in another trial with exercise as an intervention modality.

About Norwegian University Of Science And Technology

The Norwegian University of Science and Technology (NTNU) is a leading research institution dedicated to advancing knowledge and innovation in various scientific fields. Renowned for its commitment to interdisciplinary collaboration, NTNU plays a pivotal role in addressing global health challenges through rigorous clinical trials and research initiatives. The university's emphasis on cutting-edge technology and its strong partnerships with healthcare sectors position it as a key player in translational research, ensuring that findings contribute effectively to improving public health and patient care. With a focus on ethical standards and scientific integrity, NTNU is dedicated to fostering advancements that enhance the quality of life and health outcomes for diverse populations.

Locations

Trondheim, , Norway

Patients applied

0 patients applied

Trial Officials

Øystein Risa

Study Director

Norwegian University of Science and Technology

Kaare Bønaa, MD prof

Principal Investigator

Norwegian University of Science and Technology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials